Goldman Sachs’s Lyra Therapeutics LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$46.8K Sell
2024
Q4
$115K Buy
2024
Q3
$141K Buy
2024
Q2
$6.75K Sell
2024
Q1
$2.08M Buy
2023
Q4
$68.5K Buy
2021
Q3
Sell
2021
Q2
$86K Sell
2021
Q1
$127K Buy
2020
Q4
$123K Buy
2020
Q3
Sell
2020
Q2
$290K Buy